Schrödinger Gestione
Gestione criteri di controllo 0/4
Informazioni chiave
Ramy Farid
Amministratore delegato
US$3.1m
Compenso totale
| Percentuale dello stipendio del CEO | 21.7% |
| Mandato del CEO | 16.8yrs |
| Proprietà del CEO | 0.3% |
| Durata media del management | 7.1yrs |
| Durata media del Consiglio di amministrazione | 5.6yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$201m |
| Mar 31 2024 | n/a | n/a | -US$143m |
| Dec 31 2023 | US$3m | US$677k | US$41m |
| Sep 30 2023 | n/a | n/a | US$44m |
| Jun 30 2023 | n/a | n/a | US$66m |
| Mar 31 2023 | n/a | n/a | US$14m |
| Dec 31 2022 | US$4m | US$651k | -US$149m |
| Sep 30 2022 | n/a | n/a | -US$153m |
| Jun 30 2022 | n/a | n/a | -US$148m |
| Mar 31 2022 | n/a | n/a | -US$135m |
| Dec 31 2021 | US$8m | US$620k | -US$100m |
| Sep 30 2021 | n/a | n/a | -US$81m |
| Jun 30 2021 | n/a | n/a | -US$42m |
| Mar 31 2021 | n/a | n/a | -US$11m |
| Dec 31 2020 | US$9m | US$526k | -US$24m |
| Sep 30 2020 | n/a | n/a | -US$20m |
| Jun 30 2020 | n/a | n/a | -US$35m |
| Mar 31 2020 | n/a | n/a | -US$33m |
| Dec 31 2019 | US$633k | US$478k | -US$25m |
| Sep 30 2019 | n/a | n/a | -US$24m |
| Jun 30 2019 | n/a | n/a | -US$24m |
| Mar 31 2019 | n/a | n/a | -US$29m |
| Dec 31 2018 | US$1m | US$464k | -US$28m |
AMMINISTRATORE DELEGATO
Ramy Farid (59 yo)
16.8yrs
Mandato
US$3,124,165
Compensazione
Dr. Ramy Farid, Ph.D. is Independent Director of Vir Biotechnology, Inc. from May 29, 2024. He serves as the President of Schrödinger, Inc. since January 2008 and has been its Chief Executive Officer since...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, President & Director | 16.8yrs | US$3.12m | 0.25% € 3.2m | |
| Co-Founder | 34.3yrs | US$1.09m | 1.7% € 21.7m | |
| Executive VP & CFO | 2.3yrs | US$1.65m | 0.0078% € 99.9k | |
| Executive VP | less than a year | US$1.70m | 0.0020% € 25.2k | |
| President of Research & Development Therapeutics | 6.6yrs | US$1.68m | 0% € 0 | |
| Chief Medical Officer | 1.3yrs | US$3.46m | 0.0031% € 39.0k | |
| Co-Founder & Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Executive VP | 7.6yrs | US$4.49m | 0.049% € 631.3k | |
| Executive VP & Chief Information Officer | 7.8yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Investor Relations & Corporate Affairs | 4.8yrs | Nessun dato | Nessun dato | |
| Corporate Secretary | 14.8yrs | US$1.47m | 0.0086% € 110.1k | |
| Senior Vice President of Materials Science | no data | Nessun dato | Nessun dato |
7.1yrs
Durata media
54.5yo
Età media
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, President & Director | 11.9yrs | US$3.12m | 0.25% € 3.2m | |
| Co-Founder | 34.3yrs | US$1.09m | 1.7% € 21.7m | |
| Co-Founder & Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Independent Chairman of the Board | 6.8yrs | US$727.05k | 0.0086% € 109.9k | |
| Independent Director | 4.6yrs | US$689.55k | 0.0086% € 109.9k | |
| Independent Director | 5.3yrs | US$707.05k | 0.0086% € 109.9k | |
| Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Independent Director | 5.8yrs | US$687.05k | 0.0086% € 109.9k | |
| Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Independent Director | 5.2yrs | US$684.55k | 0.0086% € 109.9k | |
| Independent Director | 4.6yrs | US$692.05k | 0.0086% € 109.9k |
5.6yrs
Durata media
62yo